[Severe contact dermatitis caused by Parfenac cream].
Bufexamac is an anti-inflammatory agent used as topical treatment of various pruritic diseases. Since it was put on the market, this product has been blamed for the occurrence of contact dermatitis (eczema, urticaria) and, rarely, severe toxicodermia. We report a case of severe contact dermatitis developed after application of bufexamac (Parfenac) cream. Patch-tests performed two months after the acute phase were positive (+ + +) for both Parfenac cream and bufexamac.
Collet
E
E
Service de Dermatologie, Hôpital du Bocage, Dijon.
Lacroix
M
M
Boulitrop Morvan
C
C
Dalac
S
S
Sallin
J
J
Lambert
D
D
D002019:Bufexamac / Q000008:administration & dosage / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000209:etiology* / Q000473:pathology; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged; D010328:Patch Tests
D002019:Bufexamac
Dermite de contact grave à la crème Parfenac.